VITASPRING BIOMEDICAL CO., LTD. Selling Expense
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Selling Expense of $31.79 thousand for the 9-month period ending 2020-10-31, per its 10-Q filed 2020-12-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2020-12-15
- VITASPRING BIOMEDICAL CO., LTD. selling expense for the quarter ending 2020-04-30 was $17.75K.
| Period end | Selling Expense 3 month | Selling Expense 9 month |
|---|---|---|
| 2020-10-31 | $31.79K 10-Q · filed 2020-12-15 | |
| 2020-04-30 | $17.75K 10-Q · filed 2020-06-19 |